BAT investment leaves Reinet gasping
British American Tobacco has come under increased regulatory scrutiny for its products, including e-cigarettes
Reinet suffered collateral damage as the share price of British American (BAT), which makes up the biggest share of its net asset value, dropped.
BAT and other global tobacco companies have come under increased regulatory scrutiny for their tobacco products, including e-cigarettes.
Reinet’s net asset value dropped to €4.8bn in the six months to end-September, from €5.4bn a year ago, as the share of BAT slipped to £35.845, from £46.72 a year before.
The value of Reinet’s investment in BAT shrunk to €2.738bn, from €3.606bn a year ago.
Reinet said in a statement that the US Food and Drug Administration’s continued regulation weighed on the tobacco industry.
The investment vehicle controlled by billionaire Johann Rupert holds 68.1-million shares in BAT, representing about 2.97% of BAT’s issued share capital.
Earlier in the week, BAT plummeted 11% after Wall Street Journal reported that the US government is considering banning menthol cigarettes.
But the value of Reinet’s investment in UK-based Pension Insurance Corporation rose to €R1.42bn, from €R1.206bn.
Investment in Trilantic Capital Partners dropped to €194m, from €214m.
The share price was down 1.36% to R218 in early trade on the JSE, giving Reinet a market value of R42.7bn